pregnanc
associ
import
chang
matern
immun
system
profound
consequ
fetu
newborn
infant
toler
fetu
success
pregnanc
requir
highli
regul
immunolog
environ
maternofet
interfac
matern
immun
compon
transfer
across
placenta
breastmilk
provid
protect
pathogen
earli
life
contribut
immun
develop
although
pregnanc
consid
state
immunodefici
infect
pathogen
caus
sever
diseas
pregnant
compar
nonpregn
women
vaccin
pregnanc
potenti
provid
protect
pathogen
affect
mother
newborn
infant
howev
efficaci
approach
limit
diseas
affect
matern
immun
respons
transfer
matern
immun
compon
offspr
recogn
health
mother
pregnanc
essenti
health
newborn
infant
matern
vaccin
great
potenti
reduc
morbid
mortal
mother
children
infect
pathogen
includ
influenza
viru
varicella
zoster
hepat
e
listeria
malaria
caus
sever
diseas
pregnant
compar
nonpregn
women
mechan
underli
increas
suscept
fulli
defin
pregnancyinduc
chang
matern
immun
system
may
play
role
hand
pregnant
women
also
hormon
physiolog
chang
includ
increas
level
estradiol
progesteron
decreas
pulmonari
reserv
increas
cardiac
output
may
contribut
reduc
pathogen
control
sever
clinic
symptom
discuss
emerg
evid
suggest
central
role
pathogenspecif
mechan
rather
process
common
multipl
pathogen
fig
understand
mechansim
critic
develop
intervent
protect
pregnant
women
offspr
pregnant
women
higher
morbid
studi
mortal
due
influenza
infect
compar
nonpregn
adult
pandem
mortal
observ
pregnant
women
sever
diseas
pregnant
compar
nonpregn
women
pathogenesi
underli
increas
suscept
remain
incomplet
understood
studi
indic
involv
pathogenspecif
mechan
rather
global
state
immunodefici
arrow
sever
symptom
compromis
surviv
mother
unborn
fetu
influenza
pandem
pregnant
women
influenza
particularli
toward
end
pregnanc
third
trimest
increas
diseas
sever
higher
rate
secondari
bacteri
pneumonia
increas
risk
hospit
admiss
intens
care
unit
compar
nonpregn
adult
higher
rate
stillbirth
miscarriag
preterm
birth
addit
observ
pandem
influenza
infect
pregnanc
epidemiolog
data
clearli
support
increas
risk
acquisit
infect
rather
risk
progress
sever
diseas
infect
howev
recent
systemat
review
emphas
rel
low
qualiti
avail
inform
incid
rate
sever
influenza
pregnant
women
mechan
underli
sever
influenza
pregnanc
remain
unclear
could
involv
anatom
physiolog
chang
increas
risk
respiratori
failur
reduc
immun
control
increas
inflammatori
respons
enhanc
natur
killer
nk
cell
cell
respons
influenza
infect
observ
pregnant
compar
nonpregn
women
suggest
suppress
cellmedi
immun
respons
unlik
major
contributor
diseas
sever
mous
studi
suggest
role
impair
migrat
antivir
lymphocyt
lung
increas
proinflammatori
respons
monocyt
dendrit
cell
vitro
influenza
infect
observ
pregnant
compar
nonpregn
women
suggest
role
immunopatholog
respons
influenza
vaccin
safe
immunogen
efficaci
pregnanc
demonstr
sever
random
clinic
trial
studi
evalu
role
respiratori
virus
influenza
pregnanc
howev
recent
two
matern
influenza
immun
trial
conduct
secondari
analys
respiratori
ill
data
pregnanc
describ
incid
matern
respiratori
diseas
due
respiratori
syncyti
viru
rsv
pregnanc
nepal
women
fever
respiratori
symptom
nasal
swab
collect
rsv
preval
low
incid
personyear
overal
south
africa
rsv
preval
base
presenc
respiratori
symptom
much
higher
incid
case
per
personyear
overal
rhinoviru
coronaviru
parainfluenza
virus
human
metapneumoviru
also
recent
detect
case
respiratori
viral
infect
pregnant
women
rhinoviru
describ
caus
influenzalik
ill
sever
studi
pregnant
women
middl
eastern
respiratori
syndrom
sever
acut
respiratori
syndrom
coronavirus
shown
case
report
associ
sever
diseas
pregnant
women
respiratori
virus
commonli
detect
nepal
women
fever
respiratori
symptom
common
rhinoviru
health
careseek
also
common
rang
depend
viral
etiolog
region
world
limit
access
medic
care
notabl
find
addit
rhinoviru
human
metapneumoviru
infect
fever
respiratori
symptom
pregnanc
found
associ
increas
risk
fetal
growth
restrict
manifest
low
birth
weight
smallforgestationalag
birth
overal
studi
demonstr
respiratori
viral
infect
pregnanc
may
advers
affect
matern
fetal
outcom
pregnant
women
may
increas
risk
progress
varicella
pneumon
particularli
third
trimest
mortal
rate
howev
much
data
base
case
report
knowledg
prospect
studi
conduct
compar
risk
varicella
pneumon
pregnant
versu
nonpregn
women
varicella
infect
pregnanc
associ
dissemin
diseas
advers
outcom
fetu
includ
congenit
varicella
character
limb
hypoplasia
optic
nerv
atrophi
microcephali
seizur
cutan
lesion
varicella
zoster
vaccin
routin
part
childhood
immun
seri
countri
prior
vaccin
major
individu
expos
childhood
acquisit
immun
prior
pregnanc
treatment
varicella
infect
pregnanc
acyclovir
use
live
vaccin
contraind
pregnanc
due
potenti
risk
fetal
transmiss
hepat
e
acquir
via
fecalor
transmiss
pathogen
often
associ
limit
access
run
water
basic
sanit
field
studi
viral
hepat
pregnant
versu
nonpregn
adult
incid
nona
nonb
hepat
increas
pregnant
women
vs
respect
studi
fulmin
hepat
develop
pregnant
women
compar
case
fulmin
hepat
nonpregn
women
incid
increas
second
third
trimest
compar
first
trimest
mortal
estim
pregnant
women
mechan
underli
increas
suscept
pregnant
women
hepat
e
infect
hepat
virus
clear
role
estradiol
promot
hepati
e
viru
replic
suggest
thu
far
treatment
avail
support
care
vaccin
avail
listeria
bacteri
infect
associ
consumpt
raw
meat
veget
drink
unpasteur
milk
risk
higher
hispan
popul
elderli
malign
well
pregnant
women
pregnant
women
consid
highrisk
group
develop
dissemin
diseas
commonli
manifest
bacteremia
meningoenceph
listeria
predilect
invas
placenta
associ
advers
pregnanc
outcom
includ
miscarriag
stillbirth
studi
britain
case
listeria
pregnanc
associ
intrauterin
fetal
death
neonat
infect
although
pathogenesi
sever
listeriosi
pregnanc
well
understood
may
involv
establish
infecti
reservoir
level
placenta
uncontrol
dissemin
matern
organ
malariaendem
region
pregnant
women
estim
threetim
increas
risk
sever
malaria
compar
nonpregn
adult
plasmodium
falciparum
tropism
placenta
increas
risk
low
birth
weight
preterm
birth
women
first
pregnanc
well
younger
higher
risk
multigravida
women
reflect
acquisit
antibodi
placentaadhes
parasit
consecut
pregnanc
chemoprevent
malaria
recommend
second
third
trimest
endem
area
therapi
artemesin
thought
toxic
fetal
develop
howev
use
artemisin
deriv
demonstr
safe
effect
treatment
pregnant
women
earli
pregnanc
matern
immun
transfer
across
placenta
provid
protect
sever
malaria
infant
sever
pathogen
often
asymptomat
pregnant
women
caus
seriou
threat
fetu
newborn
infant
pathogen
therefor
consid
target
immun
children
teenag
women
childbear
age
approach
success
appli
prevent
congenit
rubella
syndrom
high
incom
countri
increasingli
low
middl
incom
countri
primari
genit
herp
infect
pregnanc
may
associ
fulmin
hepat
dissemin
diseas
compar
primari
herp
simplex
viru
hsv
infect
nonpregn
adult
though
data
conclus
risk
neonat
herp
substanti
higher
women
primari
diseas
pregnanc
rather
diseas
reactiv
pregnanc
mani
women
genit
herp
asymptomat
mild
symptom
diagnosi
treatment
may
challeng
requir
use
serolog
evid
preexist
antibodi
target
popul
vaccin
herp
like
prior
onset
sexual
activ
howev
current
licens
vaccin
exist
multipl
vaccin
candid
shown
efficaci
prevent
primari
infect
howev
multipl
new
vaccin
develop
mous
studi
recent
demonstr
matern
hsv
immun
confer
protect
neonat
mortal
behavior
morbid
neonat
herp
associ
mortal
rate
untreat
rout
acquisit
commonli
exposur
genit
tract
vagin
deliveri
therefor
caesarean
section
indic
women
known
activ
genit
herp
time
deliveri
women
cytomegaloviru
cmv
infect
pregnanc
gener
exhibit
rang
diseas
sever
similar
nonpregn
adult
rang
asymptomat
infect
mononucleosislik
syndrom
fever
rash
lymphadenophathi
risk
factor
primari
cmv
infect
pregnanc
includ
exposur
infect
young
children
excret
viru
prolong
period
time
clinic
manifest
cmv
infect
fetu
includ
sensorineur
hear
loss
chorioretin
intrauterin
growth
restrict
preterm
birth
hepatosplenomegali
microcephali
fulmin
diseas
primari
infect
earli
pregnanc
associ
higher
risk
transmiss
fetu
estim
primari
infect
compar
follow
recurr
infect
recurr
infect
includ
reactiv
latent
viru
acquisit
new
strain
cmv
similar
herp
simplex
target
cmv
vaccin
would
young
children
adolesc
prior
pregnanc
number
cmv
vaccin
candid
current
develop
though
none
licens
zika
viru
reemerg
pathogen
particular
implic
pregnant
women
symptom
zika
viru
infect
pregnanc
includ
maculopapular
rash
arthralgia
conjunct
low
grade
fever
like
cmv
rubella
infect
zika
earlier
pregnanc
associ
increas
risk
congenit
birth
defect
includ
microcephali
intrauterin
growth
retard
pregnant
women
like
prolong
viremia
due
zika
viru
compar
nonpregn
adult
infect
pregnanc
associ
increas
risk
congenit
birth
defect
unit
state
center
diseas
control
guidelin
recommend
laboratori
studi
zika
viru
molecular
test
serolog
indic
women
clinic
suspicion
zika
viru
infect
histori
exposur
via
travel
resid
region
mosquitoborn
transmiss
zika
document
unprotect
sexual
contact
partner
travel
area
viral
infect
pregnanc
thought
lead
placent
infect
transmiss
fetal
neuron
cell
lead
cell
injuri
death
risk
congenit
infect
appear
high
women
document
zika
viru
infect
pregnanc
prospect
studi
brazil
infant
born
women
diagnos
infect
pregnanc
abnorm
clinic
brain
imag
find
occur
pregnanc
infect
occur
first
second
third
trimest
pregnanc
respect
specif
treatment
vaccin
current
avail
current
recommend
includ
avoid
travel
endem
area
use
barrier
contracept
protect
sexual
transmiss
use
standard
precaut
prevent
mosquito
bite
fetu
express
patern
antigen
therefor
semiallogen
graft
pregnant
women
multipl
redund
mechan
select
promot
immunolog
toler
fetu
allow
success
pregnanc
maternofet
interfac
placenta
highli
immunoregul
environ
contain
larg
number
innat
adapt
immun
cell
includ
nk
cell
lymphocyt
myeloid
cell
activ
suppress
fetal
tissu
reject
pregnanc
also
associ
signific
chang
number
function
immun
cell
system
level
recent
analys
immun
cell
respons
activ
signal
indic
dynam
coordin
chang
first
third
trimest
pregnanc
suggest
immun
clock
regul
immun
function
pregnant
women
relev
antibodi
respons
vaccin
b
cell
follicular
helper
cell
antigenpres
cell
studi
examin
influenc
pregnanc
b
cell
antigenpres
cell
impact
follicular
helper
cell
remain
assess
studi
show
pregnanc
associ
decreas
b
cell
number
peripher
blood
studi
mice
indic
estrogen
produc
pregnanc
reduc
b
cell
lymphopoiesi
studi
influenc
hormon
b
cell
function
indic
pregnanc
may
impact
product
immunoglobulin
estrogen
increas
product
immunoglobulin
g
igg
human
b
cell
prolactin
decreas
threshold
b
cell
activ
howev
total
serum
igg
level
lower
pregnant
nonpregn
women
low
high
incom
countri
set
phenomenon
probabl
involv
hemodilut
hand
popul
live
low
incom
countri
includ
pregnant
women
commonli
elev
serum
level
igg
probabl
result
high
chronic
exposur
microbi
antigen
malaria
recent
studi
indic
estrogen
stimul
product
natur
antibodi
bacteri
oligosaccharid
antibodi
transfer
mother
offspr
protect
mice
entheropathogen
escherichia
coli
infect
togeth
studi
indic
sex
hormon
pregnanc
modul
number
b
lymphocyt
product
immunoglobulin
signific
chang
qualiti
igg
also
observ
pregnanc
igg
glycoprotein
carri
nglycan
fc
fab
segment
composit
nglycan
influenc
threedimension
structur
fc
segment
igg
interact
igg
receptor
complement
total
glycovari
attach
fc
segment
igg
combin
four
igg
subclass
divers
offer
potenti
fine
tune
igg
effector
function
pregnanc
associ
increas
galactosyl
sialyl
decreas
fucosyl
total
igg
fc
chang
potenti
modul
capac
igg
activ
nk
cell
complement
reduc
inflammatori
properti
clinic
relev
modif
support
associ
igg
galactosyl
remiss
rheumatoid
arthriti
pregnant
women
mous
studi
suggest
estrogen
upregul
express
activationinduc
deaminas
enzym
initi
class
switch
recombin
somat
hypermut
immunoglobulin
impact
estrogen
pregnanc
subclass
avid
antigenspecif
igg
remain
poorli
character
chang
antigenpres
cell
also
observ
pregnant
women
absolut
number
myeloid
dendrit
cell
mdc
shown
increas
first
trimest
decreas
pregnanc
progress
reach
similar
count
third
trimest
nonpregn
women
contrast
number
plasmacytoid
p
dc
shown
reduc
third
trimest
pregnanc
result
higher
mdc
pdc
ratio
pregnanc
also
associ
chang
tolllik
receptor
tlr
express
circul
dc
subset
increas
express
mdc
pdc
detect
role
chang
modul
immun
respons
pregnanc
yet
explor
potenti
relev
modul
immun
respons
pregnanc
chang
composit
matern
microbiom
composit
divers
microbiom
influenc
pregnanc
sever
bodi
site
includ
oral
caviti
gut
genit
tract
mous
studi
suggest
chang
gut
microbiom
may
promot
inflammatori
respons
particip
physiolog
chang
metabol
associ
pregnanc
impact
pregnanc
sex
hormon
b
cell
antigenpres
cell
microbiom
suggest
possibl
influenc
magnitud
qualiti
antibodi
respons
vaccin
notion
support
observ
magnitud
antibodi
respons
vaccin
often
higher
women
men
overal
vaccin
immunogen
pregnant
women
howev
rel
control
studi
compar
vaccin
respons
pregnant
nonpregn
women
avail
data
come
studi
influenza
pertussi
immun
consist
across
studi
four
studi
describ
similar
antibodi
respons
season
influenza
vaccin
pregnant
nonpregn
women
hand
studi
report
lower
respons
pregnant
women
follow
immun
season
pandem
influenza
vaccin
whether
gestat
stage
pregnanc
affect
respons
vaccin
uncertain
similar
antibodi
respons
season
pandem
influenza
vaccin
observ
throughout
pregnanc
two
studi
wherea
recent
studi
report
declin
antibodi
respons
season
influenza
immun
rel
increas
proport
subclass
fewer
studi
examin
impact
pregnanc
antibodi
respons
pertussi
immun
two
studi
report
similar
antibodi
respons
pertussi
immun
pregnant
nonpregn
women
howev
one
two
studi
report
lower
cell
respons
pertussi
antigen
pregnant
compar
nonpregn
women
recent
studi
involv
larger
sampl
size
observ
lower
antibodi
respons
pertussi
toxin
filament
hemagglutinin
pregnant
compar
nonpregn
women
factor
respons
discord
result
obtain
differ
studi
unclear
possibl
attribut
rel
small
size
popul
includ
studi
differ
test
vaccin
particip
characterist
includ
prevaccin
antibodi
titer
import
determin
vaccin
respons
persist
antibodi
follow
matern
immun
influenc
optim
time
immun
requir
repeat
immun
consecut
pregnanc
pertussi
antibodi
decay
rapidli
support
need
immun
pregnanc
recommend
increas
number
high
incom
countri
antibodi
decay
follow
immun
adjuv
pandem
influenza
vaccin
similar
pregnant
nonpregn
women
impact
pregnanc
qualiti
antibodi
respons
vaccin
remain
larg
uncharacter
studi
show
avid
cord
blood
antibodi
higher
follow
pertussi
immun
week
compar
week
gestat
differ
like
relat
time
need
increas
antibodi
avid
follow
booster
immun
rather
impact
gestat
stage
impact
pregnanc
glycosyl
profil
function
properti
vaccineinduc
antibodi
remain
investig
evid
pregnanc
induc
chang
circul
antigenpres
cell
composit
microbiom
suggest
innat
immun
respons
inflammatori
reaction
vaccin
may
also
influenc
one
studi
pregnant
women
given
season
influenza
vaccin
increas
plasma
level
inflammatori
cytokin
first
day
vaccin
respons
similar
nonpregn
women
recent
studi
pregnant
women
like
report
moder
sever
pain
inject
site
follow
pertussi
immun
compar
nonpregn
women
occurr
local
system
reaction
follow
vaccin
similar
group
except
matern
human
immunodefici
viru
hiv
infect
impact
matern
diseas
respons
vaccin
remain
larg
uncharacter
south
africa
matern
hiv
infect
associ
lower
seroconvers
rate
season
influenza
vaccin
vaccin
efficaci
compar
observ
hivuninfect
pregnant
women
hiv
infect
also
associ
lower
immunogen
candid
glycoconjug
group
b
streptococcu
vaccin
pregnant
women
immunogen
pandem
influenza
vaccin
hivinfect
pregnant
women
correl
posit
prevaccin
immun
neg
hiv
replic
hypergammaglobulinemia
commonli
observ
pregnant
women
live
low
incom
countri
impact
antibodi
respons
vaccin
character
transfer
matern
antibodi
fetu
newborn
infant
across
placenta
breastmilk
provid
protect
infecti
pathogen
mother
expos
addit
recent
studi
indic
matern
antibodi
also
contribut
infant
gut
homeostasi
shield
commens
bacteria
impact
develop
gut
immun
system
prevent
allerg
respons
earli
life
immunoglobulin
matern
circul
igg
transfer
transplacent
studi
suggest
matern
ige
could
transport
complex
igg
transfer
antibodi
activ
process
begin
end
first
trimest
pregnanc
end
second
trimest
transplacent
antibodi
ratio
greater
birth
fullterm
newborn
result
infant
born
prematur
lower
level
matern
antibodi
increas
risk
vaccineprevent
diseas
igg
subclass
import
determin
transfer
across
placenta
antibodi
transfer
ratio
highest
lowest
transfer
igg
also
influenc
antigen
specif
transfer
polysaccharid
antigenspecif
igg
lower
protein
antigenspecif
igg
differ
like
relat
lower
transfer
howev
consider
variat
transfer
ratio
among
protein
antigenspecif
polysaccharid
antigenspecif
antibodi
suggest
factor
igg
subclass
may
play
role
among
igg
glycosyl
could
involv
inde
igg
differ
antigenspecif
differ
glycosyl
profil
studi
suggest
select
transfer
igg
express
specif
glycovari
transport
matern
igg
fetu
involv
cross
sever
placent
layer
includ
syncytiotrophoblast
fetal
endothelium
stroma
separ
two
cell
layer
neonat
fc
receptor
fcrn
main
receptor
transport
matern
igg
across
syncytiotrophoblast
follow
endocytosi
matern
circul
fc
segment
igg
bind
fcrn
acid
ph
endosom
transport
basal
surfac
syncytiotrophoblast
igg
dissoci
fcrn
physiolog
ph
fcrn
express
fetal
endotheli
cell
receptor
particip
transport
igg
fetal
circul
studi
suggest
express
fetal
endotheli
cell
could
involv
role
matern
antibodi
transfer
still
debat
better
understand
molecular
cellular
basi
matern
antibodi
transfer
across
placenta
would
help
design
vaccin
induc
antibodi
optim
transfer
fetu
matern
vaccin
deliveri
decis
vaccin
pregnanc
need
consid
sever
variabl
includ
limit
antenat
care
mani
women
develop
countri
lead
need
increas
vaccin
window
need
protect
preterm
infant
would
benefit
vaccin
late
pregnanc
optim
time
antibodi
affin
matur
transplacent
transfer
unit
state
current
recommend
administ
pertussiscontain
vaccin
pregnanc
week
gestat
requir
week
serolog
respons
follow
transplacent
antibodi
transfer
recommend
lead
atrisk
group
infant
born
earlier
week
gestat
also
highest
risk
sever
diseas
due
pertussi
also
potenti
limit
protect
infant
born
closer
term
matern
immun
perform
shortli
deliveri
recent
prospect
observ
studi
examin
concentr
antipertussi
toxin
antifilament
hemagglutinin
igg
newborn
women
receiv
second
versu
third
trimest
vaccin
overal
higher
concentr
cord
blood
antibodi
pertussi
toxin
filament
hemagglutinin
detect
follow
second
trimest
versu
third
trimest
vaccin
although
matern
vaccin
respons
measur
data
interpret
consequ
longer
durat
antibodi
transfer
follow
vaccin
second
trimest
pregnanc
immun
pertussi
recommend
second
trimest
pregnanc
sever
countri
includ
unit
kingdom
belgium
current
unit
state
influenza
vaccin
pregnanc
recommend
industri
countri
vaccin
time
pregnanc
influenza
season
mani
countri
influenza
circul
mani
month
year
includ
subtrop
asia
subsaharan
africa
set
influenza
vaccin
may
consid
yearround
vaccin
strategi
shown
efficaci
random
clinic
trial
matern
influenza
vaccin
nepal
studi
women
addit
random
second
third
trimest
vaccin
evalu
effect
infant
influenza
vaccin
efficaci
result
studi
show
signific
differ
influenza
vaccin
efficaci
second
third
trimest
vaccin
nonsignific
trend
toward
improv
birth
weight
earlier
vaccin
cord
blood
antihemagluttin
inhibit
titer
b
antigen
differ
two
group
though
number
sampl
test
small
therefor
avail
data
regard
pertussi
influenza
vaccin
time
pregnanc
suggest
earlier
vaccin
associ
decreas
efficaci
diseas
mother
infant
vaccin
second
trimest
pregnanc
offer
advantag
protect
preterm
infant
increas
potenti
window
vaccin
set
may
challeng
access
pregnant
women
studi
conduct
consolid
observ
differ
popul
limit
inform
avail
regard
impact
time
vaccin
pregnanc
vaccin
principl
optim
transfer
matern
antibodi
requir
suffici
time
matern
immun
deliveri
like
appli
studi
haemophilu
influenza
type
b
conjug
vaccin
transmiss
antibodi
greatest
mother
vaccin
week
deliveri
chronic
matern
infect
hiv
malaria
reduc
transfer
matern
igg
studi
conduct
across
differ
popul
report
associ
reduc
transfer
matern
igg
placent
malaria
trophozoit
caus
direct
invas
placenta
could
therebi
alter
igg
transfer
howev
recent
studi
papua
new
guinea
indic
decreas
transfer
may
directli
relat
placent
malaria
rather
due
hypergammaglobulinemia
hypergammaglobulinemia
result
chronic
inflamm
polyclon
b
cell
activ
gener
consid
hypergammaglobulinemia
impair
matern
antibodi
transfer
satur
fcrn
howev
studi
report
variabl
impact
matern
hypergammaglobulinemia
transplacent
transfer
accord
igg
subclass
antigenspecif
suggest
factor
involv
placent
receptor
cell
biophys
characterist
igg
may
involv
littl
know
regard
impact
hypergammaglobulinemia
transfer
igg
induc
vaccin
pregnanc
studi
low
high
incom
countri
report
decreas
transfer
matern
igg
children
born
hivinfect
mother
across
multipl
vaccin
pathogenspecif
antigen
particularli
signific
given
increas
infecti
morbid
mortal
observ
hivexpos
uninfect
compar
hivunexpos
infant
notion
support
recent
studi
conduct
belgium
show
associ
reduc
transfer
matern
antibodi
well
immun
activ
newborn
risk
hospit
infect
first
month
life
hivexpos
uninfect
infant
studi
examin
impact
matern
hiv
infect
transfer
antibodi
induc
vaccin
pregnanc
follow
pandem
influenza
vaccin
hivinfect
pregnant
women
cord
blood
antibodi
level
higher
matern
antibodi
level
studi
lower
other
variabl
could
relat
differ
activ
matern
hiv
infect
across
studi
inde
higher
transfer
ratio
matern
antibodi
observ
mother
initi
antiretrovir
therapi
compar
pregnanc
immun
hivinfect
pregnant
women
import
strategi
protect
vulner
newborn
infant
efficaci
limit
reduc
vaccin
immunogen
reduc
transfer
matern
antibodi
impact
hiv
infect
qualiti
matern
antibodi
explor
better
understand
impact
hiv
matern
immun
transfer
newborn
help
design
optim
vaccin
strategi
breastfeed
associ
improv
multitud
infant
outcom
particularli
low
middl
incom
countri
exclus
breastfeed
recommend
multipl
profession
group
first
month
life
specif
relat
infecti
risk
breastmilk
decreas
risk
sepsi
necrot
enterocol
preterm
infant
associ
decreas
risk
respiratori
viral
infect
acut
otiti
media
gastroenter
breastmilk
contain
secretori
iga
igg
compon
breastmilk
includ
lactoferrin
lysozym
white
blood
cell
predominantli
neutrophil
macrophag
hormon
growth
factor
cytokin
could
contribut
antivir
antibacteri
properti
synthesi
iga
via
plasma
cell
enteromammari
bronchomammari
immun
system
exposur
antigen
matern
plasma
cell
synthes
secretori
iga
antibodi
mammari
gland
secret
milk
polymer
ig
receptor
pigr
transport
secretori
iga
igm
breastmilk
secretori
iga
repres
major
immunoglobulin
breastmilk
follow
secretori
igm
igg
human
ingest
breastmilk
antibodi
enter
neonat
circul
secretori
antibodi
may
prevent
microbi
colon
invas
coat
mucos
surfac
studi
shown
secretori
iga
colostrum
prevent
hiv
transcytosi
across
epithelium
direct
neutral
breastmilk
igg
also
shown
protect
hiv
infect
antibodydepend
cytotox
correl
breastmilk
igg
respiratori
syncyti
viru
protect
acut
respiratori
infect
recent
report
although
role
breastmilk
antibodi
protect
diseas
wellstudi
pathogenspecif
iga
igg
induc
breastmilk
matern
immun
could
contribut
protect
immun
pregnanc
effici
strategi
protect
mother
newborn
infant
infecti
pathogen
momentum
matern
immun
grow
opportun
gain
fundament
insight
determin
matern
immun
pathogen
transfer
newborn
infant
pregnanc
associ
mani
dynam
chang
matern
immun
cell
molecul
critic
toler
fetu
chang
could
also
select
modul
matern
immun
compon
transfer
newborn
infant
therebi
provid
optim
protect
infecti
pathogen
birth
pregnanc
modifi
glycosyl
profil
matern
igg
could
also
influenc
product
individu
igg
subclass
transfer
matern
igg
placenta
potenti
breastmilk
could
select
antibodi
optim
biophys
function
profil
unravel
fundament
process
identifi
determin
magnitud
qualiti
vaccin
respons
pregnant
women
offer
potenti
optim
matern
immun
strategi
burden
infecti
diseas
affect
young
infant
low
incom
countri
preval
matern
diseas
includ
chronic
infect
also
highest
systemat
evalu
better
understand
impact
matern
diseas
vaccineinduc
immun
transfer
newborn
requir
achiev
broadest
impact
matern
immun
worldwid
